Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer

The effectiveness of preoperative (neoadjuvant) chemotherapy (NAC) for resectable pancreatic ductal adenocarcinoma (PDAC) remains unclear. The present study retrospectively evaluated the efficacy of NAC with gemcitabine (GEM)-based regimens or GEM monotherapy for resectable PDAC. Between 2006 and 20...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: Tajima, Hidehiro, Ohta, Tetsuo, Okazaki, Mitsuyoshi, Yamaguchi, Takahisa, Ohbatake, Yoshinao, Okamoto, Koichi, Nakanuma, Shinichi, Kinoshita, Jun, Makino, Isamu, Nakamura, Keishi, Miyashita, Tomoharu, Takamura, Hiroyuki, Ninomiya, Itasu, Fushida, Sachio, Nakamura, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587007/
https://ncbi.nlm.nih.gov/pubmed/31281650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1867
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados